Syros Pharmaceuticals CEO Nancy Simonian's 2023 pay falls 59% to $1.4M
Syros Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: April 23, 2024
Syros Pharmaceuticals reported fiscal year 2023 executive compensation information on April 23, 2024.
In 2023, two executives at Syros Pharmaceuticals received on average a compensation package of $1.2M, a 49% decrease compared to previous year.
Average pay of disclosed executives at Syros Pharmaceuticals
Nancy Simonian, Chief Executive Officer, received $1.4M in total, which decreased by 59% compared to 2022. 44% of Simonian's compensation, or $635K, was in salary. Simonian also received $319K in non-equity incentive plan, $477K in stock awards, as well as $5.2K in other compensation.
Eric R. Olson, Chief Scientific Officer, received a compensation package of $936K, which decreased by 44% compared to previous year. 44% of the compensation package, or $410K, was in salary.
Related executives
You may also like
Source: SEC filing on April 23, 2024.